|
|
 |
State-of-the-Science Conference on Ductal Carcinoma In Situ Slated for September
On September 22–24, NCI and the NIH Office of Medical Applications of Research will
convene a state-of-the-science conference on ductal carcinoma in situ
(DCIS) at the Natcher Conference Center on the NIH campus. The conference will address the following key questions:
- What are the incidence and prevalence of DCIS and its specific pathologic subtypes, and how are incidence and prevalence influenced by mode of detection, population characteristics, and other risk factors?
- How does the use of MRI or sentinel lymph node biopsy impact important outcomes in patients diagnosed with DCIS?
- How do local control and systemic outcomes vary in DCIS based on tumor and patient characteristics?
- In patients with DCIS, what is the impact of surgery, radiation, and systemic treatment on outcomes?
- What are the most critical research questions for the diagnosis and management of DCIS?
Invited experts will present information pertinent to these questions, and a systematic literature review will be summarized.
Conference attendees will have the opportunity to ask questions and provide statements during open discussion periods. After weighing
the scientific evidence, an unbiased, independent panel will prepare and present a consensus statement addressing the key conference questions.
The conference is free and open to the public but advance registration is recommended.
Go online to find more information and register.
—posted 7/30/2009
Molecular Targets for Cancer Prevention Symposium
The Center for Cancer Research and the Division of Cancer Prevention at the National Cancer
Institute will present the following symposium: Molecular Targets for Cancer Prevention Symposium
- February 4-5, 2009 at NIH Natcher Conference Center, Bethesda, Maryland. Evidence from both
preclinical and clinical studies will provide an exciting forum for timely discussion and debate
on the state-of-the-science, recent advances, and opportunities for discovery. Further information
is available in this flyer.
Interested investigators may register at:
http://web.ncifcrf.gov/events/cancerprevention/2009/default.asp
—posted 10/09/2008
|
|
Registration for the NCI Biospecimen Best Practices Forums is Open
The National Cancer Institute (NCI) is holding a series of public forums about the NCI
Best Practices for Biospecimen Resources, which outlines technical, operational,
ethical, legal and policy principles for biospecimen resources. The purpose of these
forums is to educate and obtain feedback about the NCI Best Practices from a broad
range of perspectives, including those of investigators, physicians, industry
representatives, hospital administrators, cancer survivors, patient advocates, and
the general public. These forums will be held on November 5, 2007, in Boston,
Massachusetts, December 3, 2007, in Chicago, Illinois, and January 28, 2008, in
Seattle, Washington, and will feature expert presentations and interactive discussions.
Attendance is free and open to the public.
—posted 10/26/2007
|
|
PLCO EEMS Winter Review Cycle Reminder
Proposals will be accepted for the PLCO EEMS winter review cycle between December 1 and
December 28, 2007. Applications will be accepted until December 28, 2007 at 5 PM ET. For more
information go to the previous PLCO communication.
—posted 10/5/2007
Availability of the Cancer Genome Atlas (TCGA) Data Portal
The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI)
would like to advise you of the availability of the initial version of The
Cancer Genome Atlas (TCGA) Data Portal. The Data Portal serves as a storage and data
management tool for TCGA data. All genomic characterization, sequencing and clinical data
from TCGA are available within the Portal.
This is the first release of the Data Portal. To help create a fully–integrated version
of the portal in the coming months, we welcome your input and feedback on this initial version.
The Data Portal can be accessed at
http://cancergenome.nih.gov/dataportal.
The Data Portal makes accessible the first of many sets of data from TCGA, and will be
continually updated as data are generated. Please check back frequently for updates,
additional data submissions, and improvements to the functionality of the database.
The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our
understanding of the molecular basis of cancer through the application of genome analysis
technologies, including large–scale genome sequencing. This 3–year pilot project was
announced in December of 2005, and after careful planning, the first funding awards were made
in the Fall of 2006.
For more information about TCGA, please visit
http://cancergenome.nih.gov.
For further assistance or to submit feedback on this version of the portal, please contact:
http://ncicb.nci.nih.gov/support. —posted 10/5/2007
»View Communication Archives
|
